Back to rankings
United States • M&A/corporate and commercial
1

Venture capital and emerging companies

William Collins

William Collins

More information
Goodwin logo

Goodwin

Goodwin’s signature technology expertise is a big draw for start-ups, while it also leverages a dominant life sciences offering that ‘provides everything a biotech company could need’. Alongside its company-side credentials, the group maintains close links with investors and it routinely advises venture capital funds on fundraisings, investments, and exits. From Boston, Mitch Bloom steers the life science practice and specializes in advising public and private life sciences companies and investors on financings, M&A, and public offerings. The technology and emerging companies team is co-led by Boston-based duo John Egan and Kenneth Gordon, together with Silicon Valley’s Craig Schmitz , all of whom act for an array of start-ups, growth companies, and investors. Other contacts in Boston include Bill Schnoor, who, as previous head of the London office, is recommended for cross-border transactions involving the technology and life sciences sectors; Danielle Lauzon, who is recognized for her cutting-edge expertise in the life sciences field; and William Collins, who excels in matters involving the biotechnology, pharmaceuticals, and medical devices spheres. In Silicon Valley, Caine Moss focuses on supporting software, AI, internet, and financial services companies through all stages of their growth.
Legal 500 Editorial commentary
Phone
6175701447
Email
[email protected]
Profile
goodwinlaw.com

Profile

Position

Partner

Career

William Collins is a partner in Goodwin’s nationally recognized Life Sciences group, counseling clients in the industries of biotechnology, pharmaceuticals and medical devices. Serving as his clients’ principal outside counsel, William provides strategic advice and corporate legal counseling to management teams and boards while structuring and leading significant transactions on his clients’ behalf. He is recognized by his clients and colleagues for his extensive industry knowledge and deal experience, and for providing practical legal and business advice. William has also been recognized as one of Law360’s Rising Stars for 2022.

William has extensive experience with startup and formation matters, venture capital financings, initial public offerings, deSPAC transactions and other equity debt capital markets transactions, mergers and acquisitions, strategic collaborations, and other complex transactions. He also represents a number of publicly traded biotechnology companies in ongoing SEC compliance, capital raising and corporate governance matters.

William has advised many of his clients through their full corporate life cycle, starting with their initial founding and funding. He also regularly represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments, exits and secondary stock sale transactions.

Education

JD, 2009, Boston University School of Law (cum laude) / BS, 2006, The University of Texas at Dallas (cum laude)

Content supplied by Goodwin

Testimonials

Collated independently by Legal 500 research team.

  • ‘Goodwin has deep knowledge of biotech governance, fundraising and transactions. The firm's breadth of practice areas provides everything a biotech company could need, from founding to exit.’

  • ‘The firm is very responsive to our needs, no matter our size.’

  • ‘William Collins is extremely responsive, highly knowledgeable and effective at leveraging his team to meet our needs. He is also unflappable, which is a significant differentiator.’

Key clients

  • Applied Intuition
  • Auradine
  • Arch Venture Partners
  • Scale AI
  • 1X
  • Heart Aerospace
  • A24 Films
  • Miro
  • Lightspeed Venture Partners
  • Vico Therapeutics BV
  • Nimbus Therapeutics
  • Obsidian Therapeutics
  • Sionna Therapeutics
  • Third Arc Bio
  • Novo Holdings A/S/F-Prime Capital Partners Life Sciences/OrbiMed Advisors LLC
  • Instride Health

Work highlights

Advised Applied Intuition on the closing of its $250m Series E financing round.
Advised Scale AI on its $1bn Series F financing transaction.
Advised Lightspeed Venture Partners, as co-lead investors, on the $1bn financing round of Wiz.